Form 4: NeuroPace Director R. Scott Huennekens Receives Equity Grant

Director R. Scott Huennekens acquired 2,890 shares of common stock and options for 5,368 shares in NeuroPace, Inc.

Summary

• Director R. Scott Huennekens was granted 2,890 shares of common stock on June 5, 2026.
• The director also received a stock option grant for 5,368 shares with an exercise price of $15.74.
• Both the common stock and the options are subject to a 12-month vesting schedule in equal monthly installments.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Retention of key leadership through a 12-month vesting schedule.

Negatives

• Minor dilution of existing shareholders due to the issuance of new equity and options.

Risks

• Continued service requirement for vesting creates dependency on the director's ongoing tenure.
• Market price volatility could impact the future value of the granted options.

Future Outlook

The equity grants are subject to continuous service requirements over the next 12 months, indicating an expectation of the director's ongoing involvement with the company.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the medical device and biotechnology sectors to ensure long-term alignment with corporate performance goals.

Comparison to Industry Standards

• The 12-month vesting period is relatively short compared to standard 3-4 year vesting schedules often seen in executive compensation, suggesting this may be a standard annual director refresh grant.

Stakeholder Impact

• Shareholders experience minor dilution from the issuance of new shares.

Next Steps

• Vesting of shares and options in 12 equal monthly installments.

Key Dates

Keywords

NeuroPace, NPCE, Form 4, Insider Trading, Equity Grant, Director Compensation